Publicaciones en las que colabora con Juan Pablo de Torres Tajes (32)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  2. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  3. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

2021

  1. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 36-41

  2. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  3. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

  4. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy

    Radiologia, Vol. 62, Núm. 2, pp. 131-138

  2. Prevalence and burden of bronchiectasis in a lung cancer screening program

    PLoS ONE, Vol. 15, Núm. 4

  3. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine

  2. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

  3. The prevalence of obstructive lung disease in a lung cancer screening cohort: Analysis of the national lung screening trial–American College of radiology image network cohort

    Annals of the American Thoracic Society

2018

  1. Pulmonary arterial enlargement predicts long-term survival in COPD patients

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients

    Respiratory Research, Vol. 18, Núm. 1

  3. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86